Cerenome, Inc. (CNSY) is a Medical pharmaceuticals company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Cerenome, Inc. in 2026. The next earnings report is expected on October 15, 2026.
Next earnings date
15 Oct 2026
In 57 days
EPS estimate
-0.86
Revenue estimate
1.4M
Past earnings
Latest earnings analysis
Cerenome missed consensus estimates in its latest quarter, with EPS of -$1.31 versus an expected -$0.88 and revenue of $411 thousand falling 63.1% short of the $1.11 million estimate. In the prior report, EPS also missed expectations while revenue came in ahead of estimates.
No dividend history available.
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
Cerenome, Inc. (CNSY) is scheduled to report earnings on October 15, 2026.
Cerenome, Inc. (CNSY) last reported earnings on August 14, 2026.
Cerenome, Inc. (CNSY) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.